The structure of mouse tumour-necrosis factor at 1.4 Å resolution:: towards modulation of its selectivity and trimerization

被引:40
作者
Baeyens, KJ
De Bondt, HL
Raeymaekers, A
Fiers, W
De Ranter, CJ
机构
[1] Lab Analyt Chem & Med Fysicochem, B-3000 Louvain, Belgium
[2] State Univ Ghent, Mol Biol Lab, B-9000 Ghent, Belgium
来源
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY | 1999年 / 55卷
关键词
D O I
10.1107/S0907444998018435
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The 1.4 Angstrom resolution structure of recombinant mouse tumour-necrosis factor or (mTNF) at 100 K has been determined. The crystals are triclinic, space group P1, with unit-cell parameters a = 48.06, b = 48.18, c = 51.01 Angstrom, alpha = 114.8, beta = 103.6, gamma = 91.1 degrees. The structure was refined to a final crystallographic R value of 19.7% (R-free = 23.3%), including 3477 protein atoms, one 2-propanol molecule, one Tris molecule and 240 water molecules Throughout the crystal lattice, the trimers are differently packed compared with human TNF, which was crystallized in the tetragonal space group P4(1)2(1)2 and refined to 2.6 Angstrom resolution. The structures of mTNF and human TNF are very similar, diverging mainly in regions that are either flexible and/or involved in crystal packing. Some loops in mTNF which contain residues important for receptor binding are better resolved than in human TNF, such as the surface-exposed loops 30-34 and 144-147, which are also important for receptor specificity. Compared with human TNFs, the channel formed by the three monomers in mTNF is narrower. One 2-propanol molecule trapped in the trimeric channel could be a lead compound for the design of TNF inhibitors.
引用
收藏
页码:772 / 778
页数:7
相关论文
共 31 条
  • [1] AGGARWAL BB, 1990, TUMOR NECROSIS FACTOR : STRUCTURE, MECHANISM OF ACTION, ROLE IN DISEASE AND THERAPY, P49
  • [2] [Anonymous], BIOL THERAPY CANC
  • [3] Crystallization and preliminary X-ray studies of mouse tumor necrosis factor
    Baeyens, KJ
    DeBondt, HL
    Raeymaekers, A
    DeRanter, CJ
    Fiers, W
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1997, 53 : 329 - 330
  • [4] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [5] DISSOCIATION OF TNF-ALPHA CYTOTOXIC AND PROINFLAMMATORY ACTIVITIES BY P55 RECEPTOR-SELECTIVE AND P75 RECEPTOR-SELECTIVE TNF-ALPHA MUTANTS
    BARBARA, JAJ
    SMITH, WB
    GAMBLE, JR
    VANOSTADE, X
    VANDENABEELE, P
    TAVERNIER, J
    FIERS, W
    VADAS, MA
    LOPEZ, AF
    [J]. EMBO JOURNAL, 1994, 13 (04) : 843 - 850
  • [6] BROUCKAERT P, 1992, LYMPHOKINE CYTOK RES, V11, P193
  • [7] Brunger A. T., 1992, X PLOR VERSION 3 1 S
  • [8] FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES
    BRUNGER, AT
    [J]. NATURE, 1992, 355 (6359) : 472 - 475
  • [9] SLOW-COOLING PROTOCOLS FOR CRYSTALLOGRAPHIC REFINEMENT BY SIMULATED ANNEALING
    BRUNGER, AT
    KRUKOWSKI, A
    ERICKSON, JW
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 : 585 - 593
  • [10] EXTENSION OF MOLECULAR REPLACEMENT - A NEW SEARCH STRATEGY BASED ON PATTERSON CORRELATION REFINEMENT
    BRUNGER, AT
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 : 46 - 57